Esperion Therapeutics
ESPR
#7628
Rank
NZ$0.51 B
Marketcap
$2.61
Share price
0.00%
Change (1 day)
-21.52%
Change (1 year)

Esperion Therapeutics (ESPR) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : NZ$1.19 Billion

According to Esperion Therapeutics's latest financial reports the company's total liabilities are NZ$1.19 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Esperion Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31NZ$1.04 B16.04%
2022-12-31NZ$0.90 B6.31%
2021-12-31NZ$0.84 B35.99%
2020-12-31NZ$0.62 B115.66%
2019-12-31NZ$0.28 B201.11%
2018-12-31NZ$95.9 M105.51%
2017-12-31NZ$46.66 M94.61%
2016-12-31NZ$23.98 M97.43%
2015-12-31NZ$12.14 M-2.11%
2014-12-31NZ$12.4 M142.6%
2013-12-31NZ$5.11 M-82.97%
2012-12-31NZ$30.02 M184.53%
2011-12-31NZ$10.55 M
2002-12-31NZ$24.19 M-15.15%
2001-12-31NZ$28.51 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NZ$2.15 B 81.37%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.31 B 94.49%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$217.28 B 18,151.47%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$14.62 B 1,128.34%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.02 B-13.64%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.24 B-79.16%๐Ÿ‡บ๐Ÿ‡ธ USA